Loading...
Loading...
Analysts at Canaccord Genuity initiated coverage on shares of Radius Health
RDUS with a Buy rating.
The target price for Radius Health is set to $21.
Radius Health's shares dropped 2.57% to close at $12.14 yesterday.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in